| BSE: 531739 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE509C01026 |
| BSE 00:00 | 20 Nov | 2.78 |
-0.15 (-5.12%) |
OPEN
2.90 |
HIGH
2.94 |
LOW
2.71 |
| NSE 05:30 | 01 Jan | Gennex Laboratories Ltd |
| OPEN | 2.90 |
| PREVIOUS CLOSE | 2.93 |
| VOLUME | 159458 |
| 52-Week high | 4.66 |
| 52-Week low | 2.28 |
| P/E | 13.90 |
| Mkt Cap.(Rs cr) | 35 |
| Buy Price | 2.78 |
| Buy Qty | 2661.00 |
| Sell Price | 2.84 |
| Sell Qty | 4949.00 |
1.52 pm | 20 Nov 2019 | Business Standard
Among other individual stocks, Lupin, Dr Reddy's Laboratories, Divi's Laboratories and Aurobindo Pharma from the Nifty Pharma index were up 3 per cent...
1.52 pm | 20 Nov 2019 | Business Standard
Among other individual stocks, Lupin, Dr Reddy's Laboratories, Divi's Laboratories and Aurobindo Pharma from the Nifty Pharma index were up 3 per cent...
1.52 pm | 20 Nov 2019 | Business Standard
Among other individual stocks, Lupin, Dr Reddy's Laboratories, Divi's Laboratories and Aurobindo Pharma from the Nifty Pharma index were up 3 per cent...
1.52 pm | 20 Nov 2019 | Business Standard
Among other individual stocks, Lupin, Dr Reddy's Laboratories, Divi's Laboratories and Aurobindo Pharma from the Nifty Pharma index were up 3 per cent...
1.52 pm | 20 Nov 2019 | Business Standard
Among other individual stocks, Lupin, Dr Reddy's Laboratories, Divi's Laboratories and Aurobindo Pharma from the Nifty Pharma index were up 3 per cent...
4.41 pm | 19 Nov 2019 | Press Trust of India
The company had earlier received approval for the product from the United States Food and Drug Administration
1.59 pm | 19 Nov 2019 | Business Standard
The stock that hits a new lifetime high attracts more volumes resulting in higher price levels.
10.27 pm | 18 Nov 2019 | Business Standard
Analysts are upgrading their ratings as they expect sales momentum in the US and domestic markets to improve
4.36 pm | 18 Nov 2019 | Press Trust of India
The SC held former Ranbaxy promoters Malvinder Singh and Shivinder Singh guilty for violating its earlier order asking them not to divest their shares...
1.49 pm | 18 Nov 2019 | Business Standard
CLSA has increased the target price of the firm to Rs 410 from Rs 350 earlier and raised its FY20-22 earnings per share (EPS) by 3 per cent - 22 per c...
7.46 am | 18 Nov 2019 | Business Standard
Stock calls and Outlook on Nifty by Mr. Sameet Chavan, Chief Analyst- Technical & Derivatives, Angel Broking Ltd.
9.13 pm | 17 Nov 2019 | Business Standard
The promoter group shareholding in AHEL was around 30.80 per cent at the end of September, 2019, of which around 66.19 per cent is pledged, according ...
7.34 pm | 16 Nov 2019 | Press Trust of India
The tablets will be manufactured at the group's manufacturing facility at SEZ, Ahmedabad, Zydus Cadila said.
1.51 am | 16 Nov 2019 | Press Trust of India
Singh and Godhwani are accused of laundering money, punishable under sections 3 and 4 of the Prevention of Money Laundering Act
9.42 pm | 15 Nov 2019 | Bloomberg
The Supreme Court held Fortis' founders -- Malvinder Singh and Shivinder Singh -- guilty of contempt of court
9.34 pm | 15 Nov 2019 | Business Standard
As many as 63 stocks have zoomed over 1,000 per cent during this period
1.30 pm | 15 Nov 2019 | Business Standard
The Supreme Court on Friday held former Ranbaxy promoters Malvinder and Shivinder Singh guilty of contempt of court for violating its order asking the...
12.42 pm | 15 Nov 2019 | Business Standard
The Company's Unit-I facility at Lingojigudem, Bhuvanagiri Yadadri district, Telangana has been inspected by the USFDA from the November 11, to Novemb...
12.17 pm | 15 Nov 2019 | Business Standard
MNC stocks have outperformed local peers for the first time in over a decade and have also significantly outperformed the Nifty over the last 18 month...
12.17 pm | 15 Nov 2019 | Business Standard
MNC stocks have outperformed local peers for the first time in over a decade and have also significantly outperformed the Nifty over the last 18 month...
